School of Engineering fourth quarter 2021 awards
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes.
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes.
Tiny Tides is an automated fast-flow instrument that can synthesize peptide-nucleic acids in a single shot.
The targeted approach eliminated tumors in mice, with minimal side effects.
Karthish Manthiram, visiting assistant professor of chemical engineering, has been honored as Committed to Caring for encouraging students to live balanced lives.
Chemical engineers created a coating for microbes that could make it easier to deploy the organisms to treat gastrointestinal disease.
Sihao Huang, William Kuhl, Tingyu Li, Giramnah Peña-Alcántara, Sreya Vangara, and Kelly Wu will pursue graduate studies in global affairs at Tsinghua University in Beijing.
A deep learning model rapidly predicts the 3D shapes of drug-like molecules, which could accelerate the process of discovering new medicines.
Nine MIT researchers selected as finalists for 2021 prize supported by Northpond Ventures; grand prize winner to receive $250K toward commercializing her human health-related invention.
Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.
Faculty, staff, and alumni recognized for outstanding contributions to physics research, education, and policy.
The recently tenured professor, who joined the MIT faculty in 2013, studied the structure and dynamics of soft matter.
A screening method developed by MIT researchers targets hydrogen peroxide in the search for new cancer therapeutics.
Dana Al-Sulaiman, a recent postdoc with MIT’s Ibn Khaldun Fellowship for Saudi Arabian Women, has developed a cheap, minimally invasive diagnostic test for cancer.
The Common Ground for Computing Education is facilitating collaborations to develop new classes for students to pursue computational knowledge within the context of their fields of interest.
Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.